CA-A Cancer Journal for Clinicians

Papers
(The median citation count of CA-A Cancer Journal for Clinicians is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Minority groups underrepresented in hematologic cancer trials13997
Evolution of community outreach and engagement at National Cancer Institute‐Designated Cancer Centers, an evolving journey12644
Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies10941
Breast cancer in a transgender man6004
Cancer treatment and survivorship statistics, 20252004
1938
Issue Information1570
Near majority of adults favor R ratings for films with smoking714
Highlighting American Cancer Society‐funded research in CA: A Cancer Journal for Clinicians551
Cancer care for transgender and gender‐diverse people: Practical, literature‐driven recommendations from the Multinational Association of Supportive Care in Cancer500
Cancer statistics 2024: All hands on deck452
Most patients with cancer are not undergoing germline genetic testing374
Multicancer detection tests: What we know and what we don’t know313
Current treatment and future directions in the management of anal cancer309
Reirradiation: Standards, challenges, and patient‐focused strategies across tumor types280
Breast cancer: The good, the bad, and an important call to effective risk reduction strategies278
More care needed for cancer caregivers248
228
Issue Information202
Clinical practice guideline and expert consensus recommendations for rehabilitation among children with cancer: A systematic review187
Underrepresentation of Hispanic women in science, technology, engineering, mathematics, and medicine172
Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians169
Health insurance status and cancer stage at diagnosis and survival in the United States162
The evolving landscape of tissue‐agnostic therapies in precision oncology158
Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial142
Does distance deter male fertility preservation?140
Study identifies risk factors that may lead to secondary cancers133
Overlooked barriers to implementation of geriatric assessment115
Interventional gastroenterology in oncology104
Multidisciplinary management in the treatment of intrahepatic cholangiocarcinoma103
The contemporary management of cancers of the sinonasal tract in adults89
Lung cancer screening guidelines: Smoking matters, not quitting80
Medicaid expansion increases survival for patients with cancer79
Cancer survivors at greater risk for bone fractures late in life79
Screening for lung cancer78
Issue Information78
Bilateral mastectomy may not reduce mortality risk72
Issue Information72
From medical student to Editor: A note of thanks69
Interpreting and integrating genomic tests results in clinical cancer care: Overview and practical guidance69
Breast Cancer Statistics, 202267
Issue Information66
Chemotherapy‐induced taste changes affect nutrition, quality of life65
Prevention of device‐related infections in patients with cancer: Current practice and future horizons63
Clinical management of metastatic colorectal cancer in the era of precision medicine58
American Cancer Society nutrition and physical activity guideline for cancer survivors55
Cancer treatment and survivorship statistics, 202254
Better communication is key for quality‐of‐life improvement in low‐income and minority patients39
39
Issue Information37
35
Is active surveillance an alternative to surgery for some patients with esophageal cancer?34
Cancer misinformation on social media33
A pan‐tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors33
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries30
Key issues face AI deployment in cancer care29
27
Social determinants of health and US cancer screening interventions: A systematic review27
Immunotherapy combination shows longer progression‐free survival than chemotherapy alone for patients with a rare type of metastatic colorectal cancer27
Radiotheranostics in oncology: Making precision medicine possible26
Geriatric assessment for the practicing clinician: The why, what, and how25
22
Navigating financial toxicity in patients with cancer: A multidisciplinary management approach22
Issue Information22
Urothelial carcinoma: Perioperative considerations from top to bottom21
Reviewer acknowledgement 202221
Global cancer statistics: A healthy population relies on population health21
Smoking cessation support lags behind lung cancer screenings16
16
Is mandated genetic counseling needed?16
Carcinoma of unknown primary: Molecular tumor board‐based therapy16
Cancer statistics, 2025: A hinge moment for optimism to morph into hope?15
Cancer statistics forAmericanIndian andAlaskaNative individuals, 2022: Including increasing disparities in early onset colorectal cancer15
Cancer disparities for LGBTQ+ patients identified more fully15
Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer15
Issue Information13
13
Translating energy balance research from the bench to the clinic to the community: Parallel animal‐human studies in cancer12
Issue Information12
Sustained weight loss may reduce cancer risk10
Issue Information10
The evolving landscape of salivary gland tumors10
New studies examine COVID‐19 risks among cancer patients10
Study identifies signs and symptoms of colorectal cancer risk at younger ages10
Not only a Western world issue: Cancer incidence in younger individuals in the United Arab Emirates10
Genomic‐derived radiation dosage improves prediction of outcomes9
Survival outcomes used to validate version 9 of the American Joint Committee on Cancer staging system for appendiceal cancer9
American Cancer Society's report on the status of cancer disparities in the United States, 20219
An overview of real‐world data sources for oncology and considerations for research8
7
Virtual exercise regimens can help patients with cancer7
7
Issue Information7
7
How can hospitals change practice to better implement smoking cessation interventions? A systematic review6
Female erectile tissues and sexual dysfunction after pelvic radiotherapy: A scoping review5
Locally advanced lung cancer5
Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians5
Modern developments in germline pharmacogenomics for oncology prescribing5
Colon cancer blood test effective for average‐risk population4
Issue Information4
Cancer statistics for African American and Black people, 20254
Erratum to “Cancer statistics, 2024”4
4
Erectile dysfunction common within the first year after rectal cancer surgery4
Osimertinib prolongs progression‐free lung cancer survival after chemotherapy4
MCED blood test boosts cancer detection in symptomatic patients3
Issue Information3
Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus‐associated oropharyngeal cancer3
Critical care management of chimeric antigen receptor T‐cell therapy recipients3
Cancer in rural America: Improving access to clinical trials and quality of oncologic care3
3
Breast cancer survivors face greater cardiometabolic risks3
Cancer care for people with dementia: Literature overview and recommendations for practice and research3
Management of T‐cell malignancies: Bench‐to‐bedside targeting of epigenetic biology3
Patient navigation across the cancer care continuum: An overview of systematic reviews and emerging literature3
Most young female cancer survivors are at minimal risk for obstetric problems3
0.040840148925781